DE69930140T2 - Vorrichtungen und verfahren für brachytherapie - Google Patents
Vorrichtungen und verfahren für brachytherapie Download PDFInfo
- Publication number
- DE69930140T2 DE69930140T2 DE69930140T DE69930140T DE69930140T2 DE 69930140 T2 DE69930140 T2 DE 69930140T2 DE 69930140 T DE69930140 T DE 69930140T DE 69930140 T DE69930140 T DE 69930140T DE 69930140 T2 DE69930140 T2 DE 69930140T2
- Authority
- DE
- Germany
- Prior art keywords
- container
- radioactive
- seed
- seeds
- roughened
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002725 brachytherapy Methods 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims description 54
- 230000002285 radioactive effect Effects 0.000 claims abstract description 71
- 238000002604 ultrasonography Methods 0.000 claims abstract description 68
- ZCYVEMRRCGMTRW-YPZZEJLDSA-N iodine-125 Chemical compound [125I] ZCYVEMRRCGMTRW-YPZZEJLDSA-N 0.000 claims abstract description 4
- 229940044173 iodine-125 Drugs 0.000 claims abstract description 4
- KDLHZDBZIXYQEI-OIOBTWANSA-N palladium-103 Chemical compound [103Pd] KDLHZDBZIXYQEI-OIOBTWANSA-N 0.000 claims abstract description 4
- 238000007788 roughening Methods 0.000 claims description 25
- 239000000463 material Substances 0.000 claims description 17
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 15
- 239000010936 titanium Substances 0.000 claims description 15
- 239000002131 composite material Substances 0.000 claims description 13
- 229910052719 titanium Inorganic materials 0.000 claims description 13
- 230000008569 process Effects 0.000 claims description 10
- 238000007493 shaping process Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 238000000465 moulding Methods 0.000 claims description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 6
- 239000000919 ceramic Substances 0.000 claims description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 5
- 229910052737 gold Inorganic materials 0.000 claims description 5
- 239000010931 gold Substances 0.000 claims description 5
- 229910001220 stainless steel Inorganic materials 0.000 claims description 5
- 239000010935 stainless steel Substances 0.000 claims description 5
- 238000005299 abrasion Methods 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- 238000011068 loading method Methods 0.000 claims description 4
- 239000012611 container material Substances 0.000 claims description 3
- 238000005530 etching Methods 0.000 claims description 3
- 229910052697 platinum Inorganic materials 0.000 claims description 3
- 238000005422 blasting Methods 0.000 claims description 2
- 229910010293 ceramic material Inorganic materials 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims description 2
- 238000010079 rubber tapping Methods 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 229920002959 polymer blend Polymers 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 claims 1
- 238000004381 surface treatment Methods 0.000 abstract description 2
- 229910052751 metal Inorganic materials 0.000 description 35
- 239000002184 metal Substances 0.000 description 35
- 238000011282 treatment Methods 0.000 description 31
- 210000001519 tissue Anatomy 0.000 description 23
- 230000005855 radiation Effects 0.000 description 15
- 239000002775 capsule Substances 0.000 description 14
- 238000002513 implantation Methods 0.000 description 14
- 238000003384 imaging method Methods 0.000 description 13
- 238000003780 insertion Methods 0.000 description 11
- 230000037431 insertion Effects 0.000 description 11
- 239000002245 particle Substances 0.000 description 9
- 208000037803 restenosis Diseases 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- 210000002307 prostate Anatomy 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 238000012285 ultrasound imaging Methods 0.000 description 7
- 206010060862 Prostate cancer Diseases 0.000 description 6
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 6
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000007943 implant Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 238000001959 radiotherapy Methods 0.000 description 5
- 229910052709 silver Inorganic materials 0.000 description 5
- 239000004332 silver Substances 0.000 description 5
- 238000012800 visualization Methods 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 238000004980 dosimetry Methods 0.000 description 4
- 238000005553 drilling Methods 0.000 description 4
- 239000011133 lead Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 150000002739 metals Chemical class 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000003825 pressing Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000003466 welding Methods 0.000 description 4
- 239000004677 Nylon Substances 0.000 description 3
- -1 Phosphor-32 Chemical compound 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000011162 core material Substances 0.000 description 3
- 210000004351 coronary vessel Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229910001092 metal group alloy Inorganic materials 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 241001631457 Cannula Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 229910001200 Ferrotitanium Inorganic materials 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 206010057362 Underdose Diseases 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000009713 electroplating Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000010439 graphite Substances 0.000 description 2
- 229910002804 graphite Inorganic materials 0.000 description 2
- GKOZUEZYRPOHIO-IGMARMGPSA-N iridium-192 Chemical compound [192Ir] GKOZUEZYRPOHIO-IGMARMGPSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000012857 radioactive material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- WUAPFZMCVAUBPE-NJFSPNSNSA-N 188Re Chemical compound [188Re] WUAPFZMCVAUBPE-NJFSPNSNSA-N 0.000 description 1
- FDSYTWVNUJTPMA-UHFFFAOYSA-N 2-[3,9-bis(carboxymethyl)-3,6,9,15-tetrazabicyclo[9.3.1]pentadeca-1(15),11,13-trien-6-yl]acetic acid Chemical compound C1N(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC2=CC=CC1=N2 FDSYTWVNUJTPMA-UHFFFAOYSA-N 0.000 description 1
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241001226615 Asphodelus albus Species 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920004943 Delrin® Polymers 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 229920000271 Kevlar® Polymers 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229910021612 Silver iodide Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-NJFSPNSNSA-N Strontium-90 Chemical compound [90Sr] CIOAGBVUUVVLOB-NJFSPNSNSA-N 0.000 description 1
- 239000004830 Super Glue Substances 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- VWQVUPCCIRVNHF-OUBTZVSYSA-N Yttrium-90 Chemical compound [90Y] VWQVUPCCIRVNHF-OUBTZVSYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 238000010420 art technique Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000005234 chemical deposition Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000007887 coronary angioplasty Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002592 echocardiography Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000004070 electrodeposition Methods 0.000 description 1
- 238000007772 electroless plating Methods 0.000 description 1
- 238000000866 electrolytic etching Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- FGBJXOREULPLGL-UHFFFAOYSA-N ethyl cyanoacrylate Chemical compound CCOC(=O)C(=C)C#N FGBJXOREULPLGL-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 238000007733 ion plating Methods 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004761 kevlar Substances 0.000 description 1
- 238000002350 laparotomy Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002504 lithotomy Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 238000009740 moulding (composite fabrication) Methods 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- WUAPFZMCVAUBPE-IGMARMGPSA-N rhenium-186 Chemical compound [186Re] WUAPFZMCVAUBPE-IGMARMGPSA-N 0.000 description 1
- 238000005488 sandblasting Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229940045105 silver iodide Drugs 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1027—Interstitial radiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G4/00—Radioactive sources
- G21G4/04—Radioactive sources other than neutron sources
- G21G4/06—Radioactive sources other than neutron sources characterised by constructional features
- G21G4/08—Radioactive sources other than neutron sources characterised by constructional features specially adapted for medical application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3925—Markers, e.g. radio-opaque or breast lesions markers ultrasonic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N2005/1019—Sources therefor
- A61N2005/1024—Seeds
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Radiology & Medical Imaging (AREA)
- High Energy & Nuclear Physics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Radiation-Therapy Devices (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10740698P | 1998-11-06 | 1998-11-06 | |
| US107406P | 1998-11-06 | ||
| GB9826121 | 1998-11-27 | ||
| GBGB9826121.7A GB9826121D0 (en) | 1998-11-27 | 1998-11-27 | Products and methods |
| PCT/GB1999/003668 WO2000028554A1 (en) | 1998-11-06 | 1999-11-05 | Products and methods for brachytherapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69930140D1 DE69930140D1 (de) | 2006-04-27 |
| DE69930140T2 true DE69930140T2 (de) | 2006-11-23 |
Family
ID=26314749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69930140T Expired - Lifetime DE69930140T2 (de) | 1998-11-06 | 1999-11-05 | Vorrichtungen und verfahren für brachytherapie |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6632176B2 (enExample) |
| EP (1) | EP1127355B1 (enExample) |
| JP (1) | JP5296276B2 (enExample) |
| CN (1) | CN100354980C (enExample) |
| AT (1) | ATE319166T1 (enExample) |
| AU (2) | AU764698B2 (enExample) |
| BR (1) | BR9915080A (enExample) |
| CA (1) | CA2345620A1 (enExample) |
| CZ (1) | CZ20011534A3 (enExample) |
| DE (1) | DE69930140T2 (enExample) |
| DK (1) | DK1127355T3 (enExample) |
| ES (1) | ES2259480T3 (enExample) |
| IL (2) | IL142166A0 (enExample) |
| NO (1) | NO20012213L (enExample) |
| NZ (1) | NZ510602A (enExample) |
| PL (1) | PL347543A1 (enExample) |
| RU (1) | RU2251437C2 (enExample) |
| TR (1) | TR200101225T2 (enExample) |
| WO (1) | WO2000028554A1 (enExample) |
Families Citing this family (136)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8668737B2 (en) | 1997-10-10 | 2014-03-11 | Senorx, Inc. | Tissue marking implant |
| US7637948B2 (en) | 1997-10-10 | 2009-12-29 | Senorx, Inc. | Tissue marking implant |
| US20090216118A1 (en) | 2007-07-26 | 2009-08-27 | Senorx, Inc. | Polysaccharide markers |
| US7983734B2 (en) | 2003-05-23 | 2011-07-19 | Senorx, Inc. | Fibrous marker and intracorporeal delivery thereof |
| US6725083B1 (en) | 1999-02-02 | 2004-04-20 | Senorx, Inc. | Tissue site markers for in VIVO imaging |
| US8498693B2 (en) | 1999-02-02 | 2013-07-30 | Senorx, Inc. | Intracorporeal marker and marker delivery device |
| US7651505B2 (en) | 2002-06-17 | 2010-01-26 | Senorx, Inc. | Plugged tip delivery for marker placement |
| US6862470B2 (en) | 1999-02-02 | 2005-03-01 | Senorx, Inc. | Cavity-filling biopsy site markers |
| US8361082B2 (en) | 1999-02-02 | 2013-01-29 | Senorx, Inc. | Marker delivery device with releasable plug |
| US9820824B2 (en) | 1999-02-02 | 2017-11-21 | Senorx, Inc. | Deployment of polysaccharide markers for treating a site within a patent |
| US6575991B1 (en) | 1999-06-17 | 2003-06-10 | Inrad, Inc. | Apparatus for the percutaneous marking of a lesion |
| GB0011581D0 (en) * | 2000-05-15 | 2000-07-05 | Nycomed Amersham Plc | Grooved brachytherapy |
| GB0011568D0 (en) | 2000-05-15 | 2000-06-28 | Nycomed Amersham Plc | Grooved medical devices |
| CA2413822A1 (en) | 2000-07-17 | 2002-01-31 | Medi-Physics, Inc. | Carrier-free 103pd brachytherapy seeds |
| US6544185B2 (en) * | 2000-10-23 | 2003-04-08 | Valentino Montegrande | Ultrasound imaging marker and method of use |
| CA2425665C (en) | 2000-10-31 | 2013-07-16 | Cook Incorporated | Coated implantable medical device |
| BR0115087B1 (pt) | 2000-11-01 | 2011-12-27 | mÉtodo de fazer um membro radioativo para uso em braquiterapia. | |
| WO2004026111A2 (en) | 2000-11-16 | 2004-04-01 | Microspherix Llc | Flexible and/or elastic brachytherapy seed or strand |
| WO2002041786A2 (en) | 2000-11-20 | 2002-05-30 | Senorx, Inc. | Tissue site markers for in vivo imaging |
| US6875165B2 (en) | 2001-02-22 | 2005-04-05 | Retinalabs, Inc. | Method of radiation delivery to the eye |
| US6723052B2 (en) * | 2001-06-07 | 2004-04-20 | Stanley L. Mills | Echogenic medical device |
| US7094198B2 (en) * | 2001-11-02 | 2006-08-22 | Worldwide Medical Technologies, Llc | Delivery system and method for interstitial radiation therapy using seed elements with ends having one of projections and indentations |
| US7060020B2 (en) * | 2001-11-02 | 2006-06-13 | Ideamatrix, Inc. | Delivery system and method for interstitial radiation therapy |
| US7074291B2 (en) | 2001-11-02 | 2006-07-11 | Worldwide Medical Technologies, L.L.C. | Delivery system and method for interstitial radiation therapy using strands constructed with extruded strand housings |
| US7217242B2 (en) * | 2002-03-12 | 2007-05-15 | Riverside Research Institute | Ultrasonic method for visualizing brachytheraphy seeds |
| ATE412446T1 (de) | 2002-09-10 | 2008-11-15 | Cianna Medical Inc | Brachytherapievorrichtung |
| US20040092786A1 (en) * | 2002-11-08 | 2004-05-13 | Memorial Sloan-Kettering Cancer Center | Intraoperative dynamic dosimetry for prostate implants |
| US20060036158A1 (en) | 2003-11-17 | 2006-02-16 | Inrad, Inc. | Self-contained, self-piercing, side-expelling marking apparatus |
| US6997862B2 (en) | 2003-05-13 | 2006-02-14 | Ideamatrix, Inc. | Delivery system and method for interstitial radiation therapy using seed strands with custom end spacing |
| US7877133B2 (en) | 2003-05-23 | 2011-01-25 | Senorx, Inc. | Marker or filler forming fluid |
| US20050020899A1 (en) * | 2003-07-25 | 2005-01-27 | Rubicor Medical, Inc. | Post-biopsy cavity treatmetn implants and methods |
| US7744852B2 (en) * | 2003-07-25 | 2010-06-29 | Rubicor Medical, Llc | Methods and systems for marking post biopsy cavity sites |
| US7537788B2 (en) | 2003-07-25 | 2009-05-26 | Rubicor Medical, Inc. | Post-biopsy cavity treatment implants and methods |
| WO2005018736A2 (en) * | 2003-08-20 | 2005-03-03 | International Brachytherapy, S.A. | Plastic brachytherapy sources |
| US20050080314A1 (en) * | 2003-10-09 | 2005-04-14 | Terwilliger Richard A. | Shielded transport for multiple brachytheapy implants with integrated measuring and cutting board |
| US7410458B2 (en) * | 2003-11-12 | 2008-08-12 | Isoray Medical, Inc. | Brachytherapy implant seeds |
| US20050273002A1 (en) | 2004-06-04 | 2005-12-08 | Goosen Ryan L | Multi-mode imaging marker |
| WO2005079915A1 (en) | 2004-02-12 | 2005-09-01 | Neo Vista, Inc. | Methods and apparatus for intraocular brachytherapy |
| US7563222B2 (en) | 2004-02-12 | 2009-07-21 | Neovista, Inc. | Methods and apparatus for intraocular brachytherapy |
| DE602005005675D1 (de) * | 2004-06-28 | 2008-05-08 | Isoray Medical Inc | Verfahren zum trennen und reinigen von cäsium-131 von bariumnitrat |
| US7517508B2 (en) * | 2004-07-26 | 2009-04-14 | Isoray Medical, Inc. | Method of separating and purifying Yttrium-90 from Strontium-90 |
| EP1774536A1 (en) * | 2004-07-28 | 2007-04-18 | Isoray Medical, Inc. | Method of separating and purifying cesium-131 from barium carbonate |
| EP1784838A2 (en) * | 2004-08-18 | 2007-05-16 | Isoray Medical, Inc. | Method for preparing particles of radioactive powder containing cesium-131 for use in brachytherapy sources |
| US7199375B2 (en) * | 2004-10-12 | 2007-04-03 | Bard Brachytherapy, Inc. | Radiation shielding container that encloses a vial of one or more radioactive seeds |
| US8656928B2 (en) * | 2004-10-14 | 2014-02-25 | Cook Medical Technologies Llc | Echogenic medical device and method of forming echogenic surface |
| US8419656B2 (en) | 2004-11-22 | 2013-04-16 | Bard Peripheral Vascular, Inc. | Post decompression marker introducer system |
| US10357328B2 (en) | 2005-04-20 | 2019-07-23 | Bard Peripheral Vascular, Inc. and Bard Shannon Limited | Marking device with retractable cannula |
| RU2299080C2 (ru) * | 2005-05-30 | 2007-05-20 | ГУН НИИ онкологии им. проф. Н.Н. Петрова Росздрава | Способ дозиметрического планирования внутриполостной брахитерапии рака шейки матки |
| RU2299081C2 (ru) * | 2005-05-31 | 2007-05-20 | ГУН НИИ онкологии им. проф. Н.Н. Петрова Росздрава | Способ дозиметрического планирования внутриполостной брахитерапии рака тела матки |
| US7736293B2 (en) | 2005-07-22 | 2010-06-15 | Biocompatibles Uk Limited | Implants for use in brachytherapy and other radiation therapy that resist migration and rotation |
| US8187159B2 (en) | 2005-07-22 | 2012-05-29 | Biocompatibles, UK | Therapeutic member including a rail used in brachytherapy and other radiation therapy |
| US8052658B2 (en) | 2005-10-07 | 2011-11-08 | Bard Peripheral Vascular, Inc. | Drug-eluting tissue marker |
| AU2006315425A1 (en) | 2005-11-15 | 2007-05-24 | Neovista Inc. | Methods and apparatus for intraocular brachytherapy |
| US7702378B2 (en) * | 2005-11-17 | 2010-04-20 | Breast-Med, Inc. | Tissue marker for multimodality radiographic imaging |
| US11241296B2 (en) | 2005-11-17 | 2022-02-08 | Breast-Med, Inc. | Imaging fiducial markers and methods |
| US8170647B2 (en) * | 2006-01-20 | 2012-05-01 | Best Medical International, Inc | Fiduciary markers and method of use thereof |
| US9422622B2 (en) | 2006-01-30 | 2016-08-23 | Surfatek Llc | Flexible conductive single wire |
| US20100057179A1 (en) * | 2006-01-30 | 2010-03-04 | Chameleon Scientific Corporation | Conductive metal thin coatings for implantable medical sensing devices |
| US7510691B2 (en) * | 2006-02-28 | 2009-03-31 | Isoray Medical, Inc. | Method for improving the recovery of cesium-131 from barium carbonate |
| RU2314583C1 (ru) * | 2006-05-02 | 2008-01-10 | Государственное образовательное учреждение высшего профессионального образования Томский политехнический университет | Радиоактивный источник и способ его изготовления |
| US7988611B2 (en) | 2006-05-09 | 2011-08-02 | Biocompatibles Uk Limited | After-loader for positioning implants for needle delivery in brachytherapy and other radiation therapy |
| US20070265487A1 (en) * | 2006-05-09 | 2007-11-15 | Worldwide Medical Technologies Llc | Applicators for use in positioning implants for use in brachytherapy and other radiation therapy |
| US20090216063A1 (en) * | 2008-01-29 | 2009-08-27 | Biocompatibles Uk Limited | Bio-absorbable brachytherapy strands |
| US7878964B1 (en) | 2006-09-07 | 2011-02-01 | Biocompatibles Uk Limited | Echogenic spacers and strands |
| US7874976B1 (en) | 2006-09-07 | 2011-01-25 | Biocompatibles Uk Limited | Echogenic strands and spacers therein |
| US11666377B2 (en) | 2006-09-29 | 2023-06-06 | Boston Scientific Medical Device Limited | Electrosurgical device |
| US12161390B2 (en) | 2006-09-29 | 2024-12-10 | Boston Scientific Medical Device Limited | Connector system for electrosurgical device |
| US20140039315A1 (en) * | 2006-09-29 | 2014-02-06 | Baylis Medical Company Inc. | Medical devices with visibility-enhancing features |
| WO2008051749A2 (en) | 2006-10-23 | 2008-05-02 | C. R. Bard, Inc. | Breast marker |
| EP2109409B1 (en) | 2006-12-12 | 2018-09-05 | C.R.Bard, Inc. | Multiple imaging mode tissue marker |
| EP2101670B1 (en) | 2006-12-18 | 2013-07-31 | C.R.Bard, Inc. | Biopsy marker with in situ-generated imaging properties |
| JP4979402B2 (ja) * | 2007-02-07 | 2012-07-18 | 日本メジフィジックス株式会社 | 放射線源管理システム |
| RU2361635C2 (ru) * | 2007-09-25 | 2009-07-20 | Валерий Владимирович Каныгин | Установка для инсталляции терапевтического радиоактивного имплантата |
| US8721514B2 (en) * | 2007-10-26 | 2014-05-13 | Koninklijke Philips N.V. | Electromagnetic pose sensing of HDR brachytherapy applicator |
| US8311610B2 (en) | 2008-01-31 | 2012-11-13 | C. R. Bard, Inc. | Biopsy tissue marker |
| JP2011522603A (ja) | 2008-06-04 | 2011-08-04 | ネオビスタ、インコーポレイテッド | 放射線源ワイヤを前進させるための手持ち放射線送達システム |
| JP5535205B2 (ja) * | 2008-06-25 | 2014-07-02 | コーニンクレッカ フィリップス エヌ ヴェ | ブラキセラピーシステム |
| US9327061B2 (en) | 2008-09-23 | 2016-05-03 | Senorx, Inc. | Porous bioabsorbable implant |
| BRPI0823399B8 (pt) | 2008-12-30 | 2021-06-22 | Bard Inc C R | dispositivo de liberação de marcador para posicionamento de marcador de tecido |
| US8663210B2 (en) | 2009-05-13 | 2014-03-04 | Novian Health, Inc. | Methods and apparatus for performing interstitial laser therapy and interstitial brachytherapy |
| US10456594B2 (en) * | 2009-12-28 | 2019-10-29 | Koninklijke Philips N.V. | Method and apparatus for brachytherapy featuring tracking via shape-sensing |
| US9883919B2 (en) | 2010-07-21 | 2018-02-06 | Cianna Medical, Inc. | Brachytherapy apparatus, systems, and methods for using them |
| AU2012253742B2 (en) * | 2011-05-06 | 2015-04-23 | W.L. Gore & Associates, Inc. | Echogenically enhanced device |
| EP2848202A1 (en) * | 2011-05-06 | 2015-03-18 | W.L. Gore & Associates, Inc. | Echogenic sleeve |
| CN103596605A (zh) * | 2011-05-06 | 2014-02-19 | W.L.戈尔及同仁股份有限公司 | 带有回声反射覆层的装置 |
| US9492573B2 (en) * | 2011-07-06 | 2016-11-15 | Serene, Llc | Method of treating cholangiocarcinoma and apparatus |
| CN102436860B (zh) * | 2011-08-16 | 2014-01-22 | 中国工程物理研究院核物理与化学研究所 | 医用放射性籽源自动生产设备 |
| US9821145B2 (en) | 2012-03-23 | 2017-11-21 | Pressure Products Medical Supplies Inc. | Transseptal puncture apparatus and method for using the same |
| CN102646456A (zh) * | 2012-05-02 | 2012-08-22 | 王锁柱 | 同位素(α源)电池 |
| US10898291B2 (en) | 2012-05-31 | 2021-01-26 | Baylis Medical Company Inc. | Radiofrequency perforation apparatus |
| CA2794226C (en) | 2012-10-31 | 2020-10-20 | Queen's University At Kingston | Automated intraoperative ultrasound calibration |
| US11937873B2 (en) | 2013-03-12 | 2024-03-26 | Boston Scientific Medical Device Limited | Electrosurgical device having a lumen |
| JP6437469B2 (ja) | 2013-03-12 | 2018-12-12 | ベイリス メディカル カンパニー インコーポレイテッドＢａｙｌｉｓ Ｍｅｄｉｃａｌ Ｃｏｍｐａｎｙ Ｉｎｃ． | 支持構造を有する医療デバイス |
| CA3220441A1 (en) | 2013-03-15 | 2015-09-17 | Boston Scientific Medical Device Limited | Electrosurgical device having a distal aperture |
| JP6795396B2 (ja) | 2013-08-07 | 2020-12-02 | ベイリス メディカル カンパニー インコーポレイテッドＢａｙｌｉｓ Ｍｅｄｉｃａｌ Ｃｏｍｐａｎｙ Ｉｎｃ． | 組織を穿刺する方法およびデバイス |
| USD715942S1 (en) | 2013-09-24 | 2014-10-21 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
| USD715442S1 (en) | 2013-09-24 | 2014-10-14 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
| USD716450S1 (en) | 2013-09-24 | 2014-10-28 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
| USD716451S1 (en) | 2013-09-24 | 2014-10-28 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
| WO2015092768A1 (en) | 2013-12-20 | 2015-06-25 | Baylis Medical Company Inc. | Steerable medical device handle |
| US9795455B2 (en) | 2014-08-22 | 2017-10-24 | Breast-Med, Inc. | Tissue marker for multimodality radiographic imaging |
| US11324548B2 (en) | 2015-08-21 | 2022-05-10 | Baylis Medical Company Inc. | Transvascular electrosurgical devices and systems and methods of using the same |
| US10779883B2 (en) | 2015-09-09 | 2020-09-22 | Baylis Medical Company Inc. | Epicardial access system and methods |
| RU2606108C2 (ru) * | 2015-11-02 | 2017-01-10 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский радиологический центр" Министерства здравоохранения Российской Федерации (ФГБУ "НМИРЦ" Минздрава России) | Способ брахитерапии локализованного рака предстательной железы |
| US11426565B2 (en) | 2016-01-07 | 2022-08-30 | Boston Scientific Medical Device Limited | Hybrid transseptal dilator and methods of using the same |
| US12207836B2 (en) | 2016-11-01 | 2025-01-28 | Boston Scientific Medical Device Limited | Methods and devices for puncturing tissue |
| BR112020011128A2 (pt) | 2017-08-10 | 2021-05-04 | Baylis Medical Company Inc. | dispositivo de troca de calor e sensor de temperatura e método de uso |
| US10646727B2 (en) * | 2017-11-13 | 2020-05-12 | Positive Energy, Llc | Anchored brachytherapy device |
| US10874877B2 (en) * | 2017-11-13 | 2020-12-29 | Positive Energy, Llc | Anchored brachytherapy device |
| EP3579909B1 (en) | 2017-12-05 | 2020-09-09 | Pedersen, Wesley Robert | Transseptal guide wire puncture system |
| CA3091560A1 (en) * | 2018-03-08 | 2019-09-12 | Alpha Tau Medical Ltd. | Radiotherapy seeds and applicators |
| KR102849171B1 (ko) | 2018-05-08 | 2025-08-27 | 보스턴 사이언티픽 메디칼 디바이스 리미티드 | 디바이스용 결합 메커니즘들 |
| CN109752750B (zh) * | 2019-01-29 | 2024-03-26 | 上海交通大学 | 一种用于稳定释放220Rn的放射源及包含该放射源的放射装置 |
| US11504546B2 (en) | 2019-02-28 | 2022-11-22 | Cowles Ventures, Llc | Needle guidance device for brachytherapy and method of use |
| US11524176B2 (en) | 2019-03-14 | 2022-12-13 | Cowles Ventures, Llc | Locator for placement of fiducial support device method |
| US12156642B2 (en) | 2019-04-29 | 2024-12-03 | Boston Scientific Medical Device Limited | Transseptal systems, devices and methods |
| US11759190B2 (en) | 2019-10-18 | 2023-09-19 | Boston Scientific Medical Device Limited | Lock for medical devices, and related systems and methods |
| US11801087B2 (en) | 2019-11-13 | 2023-10-31 | Boston Scientific Medical Device Limited | Apparatus and methods for puncturing tissue |
| US11383093B1 (en) | 2019-12-06 | 2022-07-12 | Hoseon LEE | Radiation release capsule |
| US11724070B2 (en) | 2019-12-19 | 2023-08-15 | Boston Scientific Medical Device Limited | Methods for determining a position of a first medical device with respect to a second medical device, and related systems and medical devices |
| US11931098B2 (en) | 2020-02-19 | 2024-03-19 | Boston Scientific Medical Device Limited | System and method for carrying out a medical procedure |
| US11986209B2 (en) | 2020-02-25 | 2024-05-21 | Boston Scientific Medical Device Limited | Methods and devices for creation of communication between aorta and left atrium |
| US12082792B2 (en) | 2020-02-25 | 2024-09-10 | Boston Scientific Medical Device Limited | Systems and methods for creating a puncture between aorta and the left atrium |
| US11819243B2 (en) | 2020-03-19 | 2023-11-21 | Boston Scientific Medical Device Limited | Medical sheath and related systems and methods |
| US12011279B2 (en) | 2020-04-07 | 2024-06-18 | Boston Scientific Medical Device Limited | Electro-anatomic mapping system |
| US11826075B2 (en) | 2020-04-07 | 2023-11-28 | Boston Scientific Medical Device Limited | Elongated medical assembly |
| US12420067B2 (en) | 2020-05-12 | 2025-09-23 | Boston Scientific Medical Device Limited | Guidewire assembly |
| US11938285B2 (en) | 2020-06-17 | 2024-03-26 | Boston Scientific Medical Device Limited | Stop-movement device for elongated medical assembly |
| US11793446B2 (en) | 2020-06-17 | 2023-10-24 | Boston Scientific Medical Device Limited | Electroanatomical mapping system with visualization of energy-delivery and elongated needle assemblies |
| US11937796B2 (en) | 2020-06-18 | 2024-03-26 | Boston Scientific Medical Device Limited | Tissue-spreader assembly |
| US12343042B2 (en) | 2020-07-16 | 2025-07-01 | Boston Scientific Medical Device Limited | Pericardial puncture device and method |
| US12042178B2 (en) | 2020-07-21 | 2024-07-23 | Boston Scientific Medical Device Limited | System of medical devices and method for pericardial puncture |
| US12005202B2 (en) | 2020-08-07 | 2024-06-11 | Boston Scientific Medical Device Limited | Catheter having tissue-engaging device |
| US12396785B2 (en) | 2020-08-12 | 2025-08-26 | Boston Scientific Medical Device Limited | System of medical devices and method for pericardial puncture |
| CA3128527A1 (en) | 2020-09-10 | 2022-03-10 | Baylis Medical Company Inc. | Elongated medical catheter including marker band |
| US11980412B2 (en) | 2020-09-15 | 2024-05-14 | Boston Scientific Medical Device Limited | Elongated medical sheath |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4323055A (en) * | 1980-04-08 | 1982-04-06 | Minnesota Mining And Manufacturing Company | Radioactive iodine seed |
| US4401124A (en) * | 1981-08-13 | 1983-08-30 | Technicare Corporation | Reflection enhancement of a biopsy needle |
| US4697575A (en) * | 1984-11-21 | 1987-10-06 | Henry Ford Hospital | Delivery system for interstitial radiation therapy including substantially non-deflecting elongated member |
| US4869259A (en) * | 1988-05-17 | 1989-09-26 | Vance Products Incorporated | Echogenically enhanced surgical instrument and method for production thereof |
| US5383466A (en) * | 1993-05-14 | 1995-01-24 | Becton, Dickinson And Company | Instrument having enhanced ultrasound visibility |
| RU2089143C1 (ru) * | 1994-03-02 | 1997-09-10 | Московский научно-исследовательский институт глазных болезней им.Гельмгольца | Способ брахитерапии внутриглазных опухолей |
| US6256529B1 (en) * | 1995-07-26 | 2001-07-03 | Burdette Medical Systems, Inc. | Virtual reality 3D visualization for surgical procedures |
| US5713828A (en) * | 1995-11-27 | 1998-02-03 | International Brachytherapy S.A | Hollow-tube brachytherapy device |
| US6129670A (en) * | 1997-11-24 | 2000-10-10 | Burdette Medical Systems | Real time brachytherapy spatial registration and visualization system |
| US6360116B1 (en) * | 1998-02-27 | 2002-03-19 | Varian Medical Systems, Inc. | Brachytherapy system for prostate cancer treatment with computer implemented systems and processes to facilitate pre-operative planning and post-operative evaluations |
| AU762130B2 (en) * | 1998-07-20 | 2003-06-19 | Cook Urological Inc. | Brachytherapy device including an anti-static handle |
-
1999
- 1999-11-05 EP EP99952712A patent/EP1127355B1/en not_active Expired - Lifetime
- 1999-11-05 JP JP2000581657A patent/JP5296276B2/ja not_active Expired - Fee Related
- 1999-11-05 CN CNB998129038A patent/CN100354980C/zh not_active Expired - Fee Related
- 1999-11-05 NZ NZ510602A patent/NZ510602A/en unknown
- 1999-11-05 TR TR2001/01225T patent/TR200101225T2/xx unknown
- 1999-11-05 DK DK99952712T patent/DK1127355T3/da active
- 1999-11-05 CA CA002345620A patent/CA2345620A1/en not_active Abandoned
- 1999-11-05 WO PCT/GB1999/003668 patent/WO2000028554A1/en not_active Ceased
- 1999-11-05 RU RU2001115702/14A patent/RU2251437C2/ru not_active IP Right Cessation
- 1999-11-05 BR BR9915080-8A patent/BR9915080A/pt not_active Application Discontinuation
- 1999-11-05 DE DE69930140T patent/DE69930140T2/de not_active Expired - Lifetime
- 1999-11-05 IL IL14216699A patent/IL142166A0/xx active IP Right Grant
- 1999-11-05 AU AU64821/99A patent/AU764698B2/en not_active Ceased
- 1999-11-05 PL PL99347543A patent/PL347543A1/xx unknown
- 1999-11-05 CZ CZ20011534A patent/CZ20011534A3/cs unknown
- 1999-11-05 ES ES99952712T patent/ES2259480T3/es not_active Expired - Lifetime
- 1999-11-05 AT AT99952712T patent/ATE319166T1/de not_active IP Right Cessation
-
2001
- 2001-03-21 IL IL142166A patent/IL142166A/en not_active IP Right Cessation
- 2001-05-04 NO NO20012213A patent/NO20012213L/no not_active Application Discontinuation
- 2001-05-17 US US09/860,011 patent/US6632176B2/en not_active Expired - Fee Related
-
2003
- 2003-11-21 AU AU2003262506A patent/AU2003262506B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU6482199A (en) | 2000-05-29 |
| AU2003262506B2 (en) | 2007-05-24 |
| EP1127355B1 (en) | 2006-03-01 |
| ES2259480T3 (es) | 2006-10-01 |
| WO2000028554A1 (en) | 2000-05-18 |
| NO20012213D0 (no) | 2001-05-04 |
| IL142166A0 (en) | 2002-03-10 |
| TR200101225T2 (tr) | 2001-09-21 |
| JP5296276B2 (ja) | 2013-09-25 |
| JP2002529480A (ja) | 2002-09-10 |
| ATE319166T1 (de) | 2006-03-15 |
| CZ20011534A3 (cs) | 2001-09-12 |
| CN100354980C (zh) | 2007-12-12 |
| AU764698B2 (en) | 2003-08-28 |
| US20020022781A1 (en) | 2002-02-21 |
| IL142166A (en) | 2006-07-05 |
| EP1127355A1 (en) | 2001-08-29 |
| DE69930140D1 (de) | 2006-04-27 |
| CN1325534A (zh) | 2001-12-05 |
| BR9915080A (pt) | 2001-07-17 |
| CA2345620A1 (en) | 2000-05-18 |
| DK1127355T3 (da) | 2006-07-03 |
| NO20012213L (no) | 2001-05-04 |
| US6632176B2 (en) | 2003-10-14 |
| RU2251437C2 (ru) | 2005-05-10 |
| PL347543A1 (en) | 2002-04-08 |
| NZ510602A (en) | 2003-08-29 |
| AU2003262506A1 (en) | 2003-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69930140T2 (de) | Vorrichtungen und verfahren für brachytherapie | |
| DE60123853T2 (de) | Gerillte Quellen zur Brachytherapie | |
| US6689043B1 (en) | Products and methods for brachytherapy | |
| JP2002529480A5 (enExample) | ||
| AU2001246736A1 (en) | Grooved brachytherapy sources | |
| US20030158480A1 (en) | Grooved medical devices with enhanced ultrasound visibility | |
| US8560052B2 (en) | Echogenic medical device | |
| DE60034317T2 (de) | Medizinische instrumente und vorrichtungen mit verbesserter ultraschall-sichtbarkeit | |
| MXPA01004519A (en) | Products and methods for brachytherapy | |
| ZA200102695B (en) | Products and methods of brachytherapy. | |
| EP1463439A2 (en) | Method for ultrasonically profiling the distribution of an administered medicament |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8328 | Change in the person/name/address of the agent |
Representative=s name: HAMMONDS LLP, LONDON, GB |
|
| R082 | Change of representative |
Ref document number: 1127355 Country of ref document: EP Representative=s name: J D REYNOLDS & CO., GB |